REINSURANCE GROUP OF AMERICA, INCORPORATED

Ratings Reinsurance Group of America, Incorporated

Equities

RGA

US7593516047

Market Closed - Nyse Other stock markets 04:00:02 2023-12-08 pm EST			5-day change	1st Jan Change
163.64 ^USD	+0.55%		+0.10%	+15.17%

Dec. 06	Reinsurance Group of America, Incorporated Launches Ruby Reinsurance Company	CI
Nov. 15	Morgan Stanley Adjusts Reinsurance Group of America Price Target to $170 From $164, Maintains Equal Weight Rating	MT

Summary

The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

The earnings growth currently anticipated by analysts for the coming years is particularly strong.
The company's attractive earnings multiples are brought to light by a P/E ratio at 10.64 for the current year.
The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
Over the past four months, analysts' average price target has been revised upwards significantly.
Consensus analysts have strongly revised their opinion of the company over the past 12 months.
There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Historically, the company has been releasing figures that are above expectations.

Ratings chart - Surperformance

Chart ESG Refinitiv

Sector : Reinsurance

	1st Jan change	Capi.	Investor Rating	ESG Refinitiv
REINSURANCE GROUP OF AMERICA, INCORPORATED	+15.17%	10 785 M $		B
PT MASKAPAI REASURANSI INDONESIA TBK	-53.60%	67 M $	-	D+

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Environment

Emissions

Innovation

Use of resources

Governance

CSR Strategy

Management

Shareholders

Controversy

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes